← Eichor
Study identifier: NCT06831461 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

Condition: Primary Brain Tumors · Diffuse Glioma · Meningioma  ·  Sponsor: Tata Memorial Centre

PhaseNA
Planned participants156
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study will be done in adults with brain tumors having good prognosis requiring treatment with radiotherapy. The current practice for brain radiotherapy involves treatment using X rays (photon radiotherapy). Proton beam therapy is a more advanced form of delivering radiation, which allows the reduction of the dose of radiation to the parts of the brain surrounding the tumor. After treatment with photon radiotherapy, certain late effects of radiation, like memory decline, hormonal deficits, hearing loss, and worsening of neurological function, can occur in some patients. From the evaluation of dose profiling, proton beam therapy has the potential to reduce the possibility of side effects by reducing the dose to critical organs. However, there is no clinical data to demonstrate whether the theoretical dose reduction translates to a clinically meaningful benefit. In the proposed study, 156 patients will be randomly allocated to either proton or photon radiotherapy in 1: 1 ratio. The primary objective of the study is to explore whether proton therapy improves functional survival, which is life expectancy without recurrence, death, or complications from radiotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Archya Dasgupta, MBBS MD  ·  8097081506  ·  archya1010@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tata Memorial CentreMumbai, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06831461